Skip to main content

Table 3 Dominant drug type and transition of drug type over 3 months intervals stratified for women and men

From: Sex-specific differences and how to handle them in early psoriatic arthritis

Timepoint Previous DMARD use DMARD use
Women Men
Methotrexate Steroids cs-DMARDs b-DMARDs no DMARD Methotrexate Steroids Cs-DMARDs b-DMARDs None
Baseline   54% 1% 12% 2% 32% 56% 2% 6% 4% 33%
T3 Methotrexate 77% 1% 6% 6% 10% 88%   4% 1% 7%
Steroids 50% 50%     40% 40% 20%   
cs-DMARDs 17%   63%   20% 18%   65%   18%
b-DMARDs     100%      91% 9%
None 13%   4%   84% 11%   1% 1% 87%
T6 Methotrexate 88%   5% 3% 4% 82% 1% 2% 6% 9%
Steroids 50% 50%      100%    
cs-DMARDs 13%   81%   6% 5%   79% 5% 11%
b-DMARDs 13%    73% 13%    7% 79% 14%
None 10%   5% 3% 81% 9% 1% 1% 1% 87%
T9 Methotrexate 69%   12% 6% 13% 78%   5% 6% 12%
Steroids   100%     25% 25% 25%   25%
cs-DMARDs 11%   78%   11%    72% 11% 17%
b-DMARDs 22%    72% 6% 5%    79% 16%
None 7%   2% 5% 87% 4%   3%   93%
T12 Methotrexate 79%   3% 7% 11% 83% 1% 6% 3% 7%
Steroids    100%     100%    
cs-DMARDs 15%   56% 15% 15% 6%   67% 11% 17%
b-DMARDs 5%    86% 10% 4%    85% 12%
None 13%   6% 1% 80% 12% 1% 5% 1% 80%
  1. *cs-DMARD, conventional synthetic DMARDS excluding methotrexate